首页> 外国专利> methods to elicit a mucosal immune response to group a streptococcal bacteria and to induce mucosal immunity, method of treatment or prevention of an infection and composition

methods to elicit a mucosal immune response to group a streptococcal bacteria and to induce mucosal immunity, method of treatment or prevention of an infection and composition

机译:引起对链球菌细菌分组并诱导粘膜免疫的粘膜免疫应答的方法,治疗或预防感染的方法和组合物

摘要

a modified p145 peptide with increased mucosal immunogenicity for use in inducing a mucosal immune response to group a streptococcal bacteria in a mammal such as a human. intramuscular administration of the modified p145 peptide can be particularly effective. a peptide or s2 variant can be co-administered with the modified p145 peptide to improve the immune response.
机译:一种具有增强的粘膜免疫原性的修饰的p145肽,用于诱导粘膜免疫应答以使哺乳动物(例如人)中的链球菌属细菌分组。肌内施用修饰的p145肽可以是特别有效的。可以将肽或s2变体与修饰的p145肽共同施用以改善免疫应答。

著录项

  • 公开/公告号BR112020003734A2

    专利类型

  • 公开/公告日2020-09-01

    原文格式PDF

  • 申请/专利权人 GRIFFITH UNIVERSITY;

    申请/专利号BR20201103734

  • 申请日2018-08-22

  • 分类号A61K39/02;A61K39/40;A61P31/04;C07K4/04;C07K14/315;C07K16/12;

  • 国家 BR

  • 入库时间 2022-08-21 11:18:21

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号